265 related articles for article (PubMed ID: 25822857)
1. Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection.
Daugule I; Ruskule A; Moisejevs G; Rudzite D; Jonaitis L; Janciauskas D; Kiudelis G; Kupcinskas L; Leja M
Eur J Gastroenterol Hepatol; 2015 May; 27(5):501-5. PubMed ID: 25822857
[TBL] [Abstract][Full Text] [Related]
2. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
[TBL] [Abstract][Full Text] [Related]
3. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
5. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
[TBL] [Abstract][Full Text] [Related]
6. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
7. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Moreno L; Martín de Argila C
Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
10. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
[TBL] [Abstract][Full Text] [Related]
11. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
[TBL] [Abstract][Full Text] [Related]
13. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Gong Y; Wei W; Yuan Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
[TBL] [Abstract][Full Text] [Related]
14. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
Lopes AI; Palha A; Lopes T; Monteiro L; Oleastro M; Fernandes A
Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
[TBL] [Abstract][Full Text] [Related]
15. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Long Q; Flanders WD; Bostick RM; Yuan Y
Int J Cancer; 2015 Jan; 136(2):425-34. PubMed ID: 24895149
[TBL] [Abstract][Full Text] [Related]
16. Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
Liu H; Fei C; Zhang J
Lab Med; 2021 Jan; 52(1):57-63. PubMed ID: 32702129
[TBL] [Abstract][Full Text] [Related]
17. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
18. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME
Ter Arkh; 2006; 78(2):26-31. PubMed ID: 16613092
[TBL] [Abstract][Full Text] [Related]
19. Examination of serum pepsinogen in functional dyspepsia.
Tahara T; Shibata T; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Yamada H; Nakamura M; Arisawa T; Hirata I
Hepatogastroenterology; 2012; 59(120):2516-22. PubMed ID: 23178618
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study.
Kassem E; Naamna M; Mawassy K; Beer-Davidson G; Muhsen K
Eur J Pediatr; 2017 Aug; 176(8):1099-1105. PubMed ID: 28681188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
